home / stock / dbvt / dbvt news

DBVT News and Press, DBV Technologies S.A. From 10/27/21

Stock Information
Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com
Menu
DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...
DBVT - GHSI, MYSZ and LEJU among mid-day movers

Gainers: Siyata Mobile (NASDAQ:SYTA) +179%. AgriFORCE (NASDAQ:AGRI) +180%. China XD Plastics (NASDAQ:CXDC) +70%. Pasithea (NASDAQ:KTTA) +46%. Enphase (NASDAQ:ENPH) +28%. Kaival Brands (NASDAQ:KAVL) +25%. Leju Holdings (NYSE:LEJU) +24%. Volcon (NASDAQ:VLCN) +22%. Nurix (NASDAQ:NRIX) +22%. Guar...
DBVT - G Medical Innovations, Guardion Health Sciences leads healthcare gainers; Cortexyme, BIMI International Medical among major losers

Gainers: G Medical Innovations (NASDAQ:GMVD) +18%, Guardion Health Sciences (NASDAQ:GHSI) +12%, Nurix Therapeutics NRIX +11%, Privia Health (NASDAQ:PRVA) +8%, Monopar Therapeutics MNPR +7%. Losers: Cortexyme (NASDAQ:CRTX) -75%, BIMI Inter...

DBVT - EVGOW and RDBXW among after hour movers

Gainers: Enphase Energy ENPH +12%. Tenable Holdings TENB +10%. Aware AWRE +8%. Marqeta MQ +6%. EVgo (NASDAQ:EVGOW) +583%. Losers: Cortexym CRTX -72%. Angion Biomedica ANGN -56%. DBV Technologies DBVT -28%. Redbox Entertainment (NASDAQ:RDBXW) -16%. ...

DBVT - DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments

Montrouge, France, October 26, 2021 DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-s...
DBVT - Jasper Therapeutics, 23andMe leads healthcare gainers; Grove, Myomo among major losers

Gainers: Jasper Therapeutics (NASDAQ:JSPR) +22%, 23andMe (NASDAQ:ME) +21%, DBV Technologies (NASDAQ:DBVT) +10%, ABVC BioPharma (NASDAQ:ABVC) +10%, Sonoma Pharmaceuticals (NASDAQ:SNOA) +8% Losers: Grove (NASDAQ:GRVI) -12%, Myomo (NYSE:MYO) -11%...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Pari...

DBVT - Tracking Baker Brothers Portfolio - Q2 2021 Update

Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...
DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris I...

DBVT - DBV Technologies to Participate at Upcoming Investor Conferences

Montrouge, France, August 31, 2021 DBV Technologies to P articipate at Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that DBV Tech...

DBVT - Beyond Air® Announces CFO Transition

GARDEN CITY, N.Y., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections an...
Previous 10 Next 10